FOR IMMEDIATE RELEASE
FROM MARY ANN LIEBERT, INC., PUBLISHERS
New Rochelle, NY, August 22, 2025—The American Thyroid Association has released new guidelines for the management of adult patients with differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid. The guidelines are published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®). Click here to read the article now.
The new guidelines, developed by an ATA task force led by Co-Chairs Matthew Ringel, MD, from The Ohio State University College of Medicine and Comprehensive Cancer Center, and Julie Ann Sosa, MD, from the University of California San Francisco, include input from a large, diverse complement of stakeholders. The panel included members from multiple specialties involved in thyroid cancer care, including a patient advocate and an expert in systematic reviews/meta-analyses/guidelines who educated and supported task force members. Jacqueline Jonklaas, MD, PhD, ATA President, noted that “ATA leadership is grateful to the task force members, ably lead by Drs. Ringel and Sosa, for this superlative clinical practice guideline that I believe will help set the standard of care for future generations of patients with thyroid cancer.”
These revised guidelines begin with the initial cancer diagnosis and continue with recommendations for staging and risk assessment; initial treatment decisions; assessment of treatment responses; monitoring approaches; diagnostic testing; and subsequent therapies based on the strength of evidence for response and consideration of side-effects and outcomes. Patient-reported outcomes, thyroid cancer survivorship, and identified areas of need for additional high-quality research are highlighted. “This thyroid cancer guideline continues the ATA’s leadership in providing high quality and evidence-based guidelines which provide thoughtful guidance to clinicians taking care of patients with thyroid cancer,” said Christopher McCabe, PhD, ATA Secretary and Chief Operating Officer.
About the Journal
Thyroid®, the official journal of the American Thyroid Association®, (ATA®) is an authoritative peer-reviewed journal published monthly online with open access options and in print. Led by Editor-in-Chief Anna M. Sawka, MD, PhD, University of Toronto, the Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid® website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Trevor E. Angell, MD and published monthly, and the groundbreaking videojournal companion VideoEndocrinology, led by Editor Catherine F. Sinclair, MD, FRACS. Complete tables of content and sample issues may be viewed on the Thyroid® website.
About the American Thyroid Association®
The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative and diverse community. ATA® is an international professional medical society with over 1,800 members from 43 countries around the world. The ATA® promotes thyroid awareness and information through Clinical Thyroidology®, a resource that summarizes research for patients and families, and extensive, authoritative resources on thyroid disease and thyroid cancer in both English and Spanish. The ATA® website www.thyroid.org serves as a bonafide clinical resource for patients and the public who look for reliable thyroid-related information.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to publishing and delivering impactful peer-reviewed research in biotechnology & life sciences, specialized clinical medicine, public health and policy, and technology & engineering. Since its founding in 1980, the company has focused on providing critical insights and content that empower researchers and clinicians worldwide to drive innovation and discovery.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.